Mukhopadhyay Banibrata, Chinchole Shashikant, Lobo Valentine, Gang Sishir, Rajapurkar Mohan
Department of Biochemistry, Muljibhai Patel Urological Hospital, 387 001 Nadiad, Gujarat India.
Indian J Clin Biochem. 2004 Jul;19(2):14-9. doi: 10.1007/BF02894251.
Serum creatinine does not distinguish between various causes of graft dysfunction. Serial assay of proximal tubular enzymes N-Acetyl-D-glucosaminidase (NAG), Alanine aminopeptidase (AAP) and Gamma glutamyl transferase (GGT) in urine was done to assess their usefulness in distinguishing various causes of graft dysfunction. Daily serum creatinine and enzymuria were measured in 32 consecutive renal allograft recipients for first 15 postoperative days. Graft dysfunction was defined as >20% increase in serum creatinine and >100% increase in enzymuria over the baseline. The diagnosis of graft dysfunction was based upon clinical criteria, ultrasonography, cyclosporin trough level, allograft biopsy, response to anti-rejection therapy and alteration of cyclosporin dosage. Fifteen episodes of graft dysfunction were identified in 15 patients. The sensitivity and specificity of the enzymes (NAG, AAP and GGT) for predicting graft dysfunction were 87.5%, 86.9%, 88.5% and 98.2%, 98.2%, 97.9% respectively. There was a significant increase in enzymuria during acute tubular necrosis (ATN) and acute rejection episode compared to cyclosporin nephrotoxicity (p<0.01). Enzymuria assay provides a simple, reliable and noninvasive method to distinguish cyclosporin nephrotoxicity from acute tubular necrosis and acute rejection in renal allograft recipients.
血清肌酐无法区分移植肾功能障碍的各种病因。对尿中近端肾小管酶N - 乙酰 - D - 氨基葡萄糖苷酶(NAG)、丙氨酸氨基肽酶(AAP)和γ - 谷氨酰转移酶(GGT)进行连续检测,以评估它们在区分移植肾功能障碍各种病因方面的作用。对32例连续的肾移植受者在术后前15天每日测定血清肌酐和酶尿。移植肾功能障碍定义为血清肌酐较基线水平升高>20%,酶尿较基线水平升高>100%。移植肾功能障碍的诊断基于临床标准、超声检查、环孢素谷浓度、移植肾活检、抗排斥治疗反应及环孢素剂量的改变。15例患者中发现了15次移植肾功能障碍发作。这些酶(NAG、AAP和GGT)预测移植肾功能障碍的敏感性分别为87.5%、86.9%、88.5%,特异性分别为98.2%、98.2%、97.9%。与环孢素肾毒性相比,急性肾小管坏死(ATN)和急性排斥发作期间酶尿显著增加(p<0.01)。酶尿检测为区分肾移植受者的环孢素肾毒性与急性肾小管坏死及急性排斥提供了一种简单、可靠且无创的方法。